Characteristics of primary cutaneous lymphoma according to WHO-EORTC classification in Korea

Clinical and Experimental Dermatology

Volumn 38, Issue 5, 2013, Pages 457-463

  Lee, Ji Hyun ^a,b   Lee, Ji Hae ^a,b   Yoo, D S ^b   Kang, H ^b   Kim, G M ^a,b   Park, H J ^b   Park, C J ^b   Lee, J D ^b   Lee, J Y ^b   Kim, S Y ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER SURVIVAL; CD30+ LYMPHOPROLIFERATIVE DISORDER; CHILD; CUTANEOUS T CELL LYMPHOMA; DEMOGRAPHY; FEMALE; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; KOREA; LARGE CELL LYMPHOMA; LYMPHOMATOID PAPULOSIS; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; MEDICAL RECORD REVIEW; MYCOSIS FUNGOIDES; NK T CELL LYMPHOMA; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX RATIO; SEZARY SYNDROME; SKIN LYMPHOMA; SUBCUTANEOUS T CELL LYMPHOMA; SURVIVAL RATE; T CELL LEUKEMIA; T CELL LYMPHOMA; WORLD HEALTH ORGANIZATION EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER CLASSIFICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84879244995     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2012.04461.x     Document Type: Article

References (17)

1. Willemze R, Jaffe ES, Burg G, et al. EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-85.
2. Kim YH, Willemze R, Pimpinelli N, et al. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110: 479-84.
3. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas. a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354-71.
4. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November, 1997. Histopathology 2000; 36: 69-86.
5. Fink-Puches R, Wolf IH, Zalaudek I, et al. Treatment of primary cutaneous B-cell lymphoma with rituximab. J Am Acad Dermatol 2005; 52: 847-53.
6. Bradford PT, Devesa SS, Anderson WF, Toro JR,. Cutaneous lymphoma incidence patterns in the United States. a population-based study of 3884 cases. Blood 2009; 113: 5064-73.
7. Dores GM, Anderson WF, Devesa SS,. Cutaneous lymphomas reported to the National Cancer Institute's surveillance, epidemiology, and end results program: applying the new WHO-European Organisation for Research and Treatment of Cancer classification system. J Clin Oncol 2005; 23: 7246-8.
8. Fujita A, Hamada T, Iwatsuki K,. Retrospective analysis of 133 patients with cutaneous lymphomas from a single Japanese medical center between 1995 and 2008. J Dermatol 2011; 38: 524-30.
9. Slater DN,. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants. Br J Dermatol 2005; 153: 874-80.
10. Groves FD, Linet MS, Travis LB, Devesa SS,. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000; 92: 1240-51.
11. Lee SS, Cho KJ, Kim CW, Kang YK,. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms. Histopathology 1999; 35: 345-54.
12. Ko YH, Kim CW, Park CS, et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 1998; 83: 806-12.
13. Morales-Suarez-Varela MM, Olsen J, Johansen P, et al. Occupational sun exposure and mycosis fungoides: a European multicenter case-control study. J Occup Environ Med 2006; 48: 390-3.
14. Lee MW,. Characteristics of cutaneous lymphomas in Korea. Clin Exp Dermatol 2003; 28: 639-46.
15. Kim YC, Yang WI, Lee MG, et al. Epstein-Barr virus in CD30 anaplastic large cell lymphoma involving the skin and lymphomatoid papulosis in South Korea. Int J Dermatol 2006; 45: 1312-16.
16. Fink-Puches R, Zenahlik P, Back B, et al. Primary cutaneous lymphomas. applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. Blood 2002; 99: 800-5.
17. Bekkenk MW, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30 (+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000; 95: 3653-61.